Karin Herrera
Technik-/Wissenschafts-/F&E-Leiter bei COMPASS THERAPEUTICS, INC.
Profil
Karin Herrera is currently the Vice President & Head-Clinical Operations at Compass Therapeutics, Inc. She previously worked as the Vice President-Clinical Operations at Kadmon Corp.
LLC.
Ms. Herrera completed her undergraduate degree at Assumption College.
Aktive Positionen von Karin Herrera
| Unternehmen | Position | Beginn |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
Ehemalige bekannte Positionen von Karin Herrera
| Unternehmen | Position | Ende |
|---|---|---|
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Karin Herrera
| Assumption College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| COMPASS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Health Technology |
